VivoSim Labs (VIVS) Inventory Average (2012 - 2024)
VivoSim Labs (VIVS) posted quarterly Inventory Average of $524000.0 for Q3 2024, up 48.65% quarter-over-quarter from $352500.0 in Q2 2024.
VivoSim Labs (VIVS) Inventory Average (2012 - 2024) Analysis & Trends
VivoSim Labs' Inventory Average history runs 9 years deep, the most recent figure standing at $524000.0 for Q3 2024.
- In Q3 2024, Inventory Average changed N/A year-over-year to $524000.0; the TTM figure through Sep 2024 stood at $524000.0 (changed N/A YoY), while the FY2019 annual figure was $666000.0, down 4.31% from the prior year.
- Inventory Average for Q3 2024 stood at $524000.0, up from $352500.0 in the prior quarter.
- The five-year high for Inventory Average was $524000.0 in Q3 2024, with the low at $352500.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | VivoSim Labs | 1.46 Mn | 1.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 352,500.00 |
| Sep 30, 2019 | 428,500.00 |
| Jun 30, 2019 | 498,000.00 |
| Mar 31, 2019 | 769,500.00 |
| Dec 31, 2018 | 1.04 Mn |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 943,000.00 |
| Mar 31, 2018 | 723,500.00 |
| Dec 31, 2017 | 550,500.00 |
| Sep 30, 2017 | 478,500.00 |
| Jun 30, 2017 | 505,500.00 |
| Mar 31, 2017 | 439,000.00 |
| Dec 31, 2016 | 386,500.00 |
| Sep 30, 2016 | 478,500.00 |
| Jun 30, 2016 | 423,000.00 |
| Mar 31, 2016 | 202,500.00 |
| Dec 31, 2015 | 69,500.00 |
| Sep 30, 2015 | 68,500.00 |
| Jun 30, 2015 | 67,500.00 |